PNC Financial Services Group
IMMU

PNC Financial Services Group’s Immunomedics Inc IMMU Stock Holding History

PNC Financial Services Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,737
Closed -$829K – 4172
2020
Q3 		$829K Sell
9,737
-477
-5% -$24.1K ﹤0.01% 1127
2020
Q2 		$362K Buy
10,214
+3,339
+49% +$97.6K ﹤0.01% 1571
2020
Q1 		$93K Buy
6,875
+204
+3% +$3.43K ﹤0.01% 2249
2019
Q4 		$141K Buy
6,671
+2,096
+46% +$37K ﹤0.01% 2292
2019
Q3 		$61K Hold
4,575
– – ﹤0.01% 2792
2019
Q2 		$63K Sell
4,575
-132,291
-97% -$1.99M ﹤0.01% 2815
2019
Q1 		$2.63M Buy
136,866
+132,283
+2,886% +$2.13M ﹤0.01% 939
2018
Q4 		$65K Sell
4,583
-1,367
-23% -$27.1K ﹤0.01% 2720
2018
Q3 		$124K Buy
5,950
+454
+8% +$10.8K ﹤0.01% 2471
2018
Q2 		$130K Sell
5,496
-49,398
-90% -$993K ﹤0.01% 2443
2018
Q1 		$802K Buy
54,894
+49,173
+860% +$803K ﹤0.01% 1411
2017
Q4 		$92K Buy
5,721
+4,000
+232% +$47.2K ﹤0.01% 2611
2017
Q3 		$24K Buy
+1,721
New +$17.2K ﹤0.01% 3309
2016
Q3 		– Sell
-714
Closed -$2K – 4414
2016
Q2 		$2K Buy
+714
New +$2.39K ﹤0.01% 4256

PNC Financial Services Group's IMMU Position: Q4 2020 in Review

PNC Financial Services Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 9,737 shares — an estimated $829K sold.

PNC Financial Services Group first reported a position in IMMU in Q2 2016 and held it in 14 quarters. The position peaked at $2.63M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • PNC Financial Services Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 9,737 Immunomedics Inc shares in Q4 2020, an estimated $829K.
  • PNC Financial Services Group first reported a position in Immunomedics Inc in Q2 2016 and held it in 14 quarters.
  • PNC Financial Services Group's Immunomedics Inc position peaked at $2.63M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.